CHARTWELL INVESTMENT PARTNERS, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 337 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARTWELL INVESTMENT PARTNERS, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$656
+28.6%
13,759
+17.0%
0.02%
+27.8%
Q1 2024$510
-22.4%
11,756
-9.4%
0.02%
-21.7%
Q4 2023$657
-100.0%
12,982
-96.0%
0.02%
-90.8%
Q1 2016$13,252,000
-28.1%
327,220
+9.9%
0.25%
-33.7%
Q4 2015$18,439,000297,7390.38%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Bellevue Group AG 9,347,926$313,529,0003.18%
Sicart Associates LLC 291,254$9,769,0002.66%
Camber Capital Management LP 2,500,000$83,850,0002.58%
SECTOR GAMMA AS 263,870$8,850,0001.76%
Parkman Healthcare Partners LLC 136,380$4,574,0001.16%
Eversept Partners, LP 450,501$15,109,8041.05%
SPHERA FUNDS MANAGEMENT LTD. 350,000$11,739,0000.99%
TANAKA CAPITAL MANAGEMENT INC 16,661$559,0000.80%
Sonora Investment Management, LLC 163,703$5,491,0000.69%
ARK Investment Management 8,511,384$285,472,0000.69%
View complete list of IONIS PHARMACEUTICALS INC shareholders